| Affiliation: | 1. Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL;2. Cancer Outcomes, Public Policy, and Effectiveness Research Center;3. Department of Internal Medicine, Yale School of Medicine, New Haven, CT;4. Department of Chronic Disease Epidemiology;5. Department of Health Policy and Management, Yale School of Public Health, New Haven, CT;2. Laboratory of Cellular Biochemistry, Division of Applied Life Sciences, Kyoto University Graduate School of Agriculture, Kyoto 606-8502, Japan;4. Department of Biochemistry & Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan;1. The First Affiliated Hospital, The Biomedical Translational Research Institute, Jinan University, Guangzhou 510632, China;2. Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA;1. Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK;2. European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen 9713, the Netherlands;3. UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK |
